Trial Site Detail

 

Drug:
Imatinib
Trial:
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

St. Herblain

     
Saint-Herblain , Loire Atlantique 44805
France

 

Principal Investigator:
 Elisabeth Bompas, Dr
Contact:
 Elisabeth BOMPAS, Dr +33 2 40 67 99 39 emmanuelle.bompas@ico.unicancer.fr
Activation Status of this Site:
 Active
Notes about this Site:
St. Herblain Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.